ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.1241
0.96%
Brent Oil
84.185
-1.27%
Bitcoin
62,131.69
3.10%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) Noticias

NUWE

Newellis (NUWE)

Newellis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NUWE
FechaHoraFuenteTítuloSímboloCompañía
25/06/202408:00GlobeNewswire Inc.Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™NASDAQ:NUWENewellis Inc
10/06/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/06/202408:00GlobeNewswire Inc.Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot PhaseNASDAQ:NUWENewellis Inc
29/05/202410:54Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NUWENewellis Inc
17/05/202416:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NUWENewellis Inc
17/05/202416:20Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NUWENewellis Inc
14/05/202408:00GlobeNewswire Inc.Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaNASDAQ:NUWENewellis Inc
09/05/202408:00GlobeNewswire Inc.Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
08/05/202416:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
08/05/202416:26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:NUWENewellis Inc
07/05/202407:00GlobeNewswire Inc.Nuwellis, Inc. Announces First Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
02/05/202408:00GlobeNewswire Inc.Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyNASDAQ:NUWENewellis Inc
30/04/202417:09GlobeNewswire Inc.Nuwellis Announces Closing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
30/04/202415:41GlobeNewswire Inc.Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:NUWENewellis Inc
26/04/202408:17GlobeNewswire Inc.Nuwellis Announces Pricing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
09/04/202408:00GlobeNewswire Inc.Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthNASDAQ:NUWENewellis Inc
11/03/202416:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUWENewellis Inc
07/03/202408:08GlobeNewswire Inc.Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
05/03/202407:00GlobeNewswire Inc.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUWENewellis Inc
05/03/202405:05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:NUWENewellis Inc
27/02/202408:00GlobeNewswire Inc.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:NUWENewellis Inc
22/02/202406:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:NUWENewellis Inc
20/02/202416:06GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
20/02/202407:42GlobeNewswire Inc.Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
08/02/202416:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
06/02/202408:00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
09/01/202416:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
04/01/202415:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
04/01/202414:05GlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
28/11/202307:00GlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Su Consulta Reciente

AMEX
TRPL
Pacer Metaurus Us Large ...
NYSE
TRIS
Tristar Acquisition I
TG
M3G
Maple Gold Mines
TG
2B4
Bonesupport Holding AB p...
TG
ALI
Almonty Industries
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados